Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma

SIMPLE SUMMARY: Intratumoral heterogeneity is believed to contribute to the immense therapy resistance and recurrence rate of glioblastoma. The aim of this retrospective study was to analyze the heterogeneity of 36 human glioblastoma samples on a morphological level by immunohistochemistry. We confi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liesche-Starnecker, Friederike, Mayer, Karoline, Kofler, Florian, Baur, Sandra, Schmidt-Graf, Friederike, Kempter, Johanna, Prokop, Georg, Pfarr, Nicole, Wei, Wu, Gempt, Jens, Combs, Stephanie E., Zimmer, Claus, Meyer, Bernhard, Wiestler, Benedikt, Schlegel, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602025/
https://www.ncbi.nlm.nih.gov/pubmed/33066251
http://dx.doi.org/10.3390/cancers12102964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602025/
https://www.ncbi.nlm.nih.gov/pubmed/33066251
http://dx.doi.org/10.3390/cancers12102964

Ejemplares similares